CardioSEAL Image

CardioSEAL & STARFlex Logo

Children's Hospital Image

Home Clinical Research
                 Trials Uses for the Devices History of Devices Other Centers

HIGH RISK TRIAL

High Risk Trial:  Is sponsored by Children's Hospital Boston.  This trial uses the CardioSEAL and STARFlex devices to close complex heart defects.  For various reasons, some patients are considered to have a higher surgical risk for device closure, such as those with complex forms of heart disease, or those with other non-cardiac medical problems.  For these patients, device closure of their heart defect with either the CardioSEAL or STARFlex device may be preferable to the conventional surgical approach.

General Entry Criteria:
  • Patient information is submitted to an independent peer-review team consisting of a cardiologist and cardiac surgeon.
  • The peer-review team assesses the medical information and must agree that the patient has a heart defect that warrants device closure, and that surgery is either risky or unlikely to be successful.
  • Willingness to comply with device study follow-up visits/testing:
      Follow-up Appointments
    • 1.  Patients need follow-up appointments at the following time intervals:
      • One month - (Timing window 2-6 weeks post implant)
      • Six months - (Timing window 4-8 months post implant)
      • Twelve months - (Timing window 8-16 months post implant)
      • Twenty-four months - (Timing window 18-30 months post implant)

    • 2.  The patients must return to the implanting center for their 6 month follow-up appointment.  All other testing may be done at the referring physician's center, but may also be done at the implanting center if the patient chooses.


Examples of the types of defects closed with the CardioSEAL and STARFlex devices are:
  • Complex muscular ventricular septal defects (single or multiple defects).
  • Patients with "leaks" near one of their heart valves.
  • Patent ductus arteriosus
  • Complex atrial septal defects